Fredun Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹213.05 crore, reflecting a quarter-on-quarter *(QoQ) increase of 32.39 per cent from ₹160.93 crore. This corresponds to a year-on-year *(YoY) growth of 27.26 per cent.
Operating Profit
Operating Profit stands at ₹28.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.64 per cent from ₹26.34 crore. This corresponds to a year-on-year *(YoY) growth of 67.42 per cent.
PBDT
PBDT stands at ₹14.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.75 per cent from ₹15.78 crore. This corresponds to a year-on-year *(YoY) growth of 58.24 per cent.
Profit Before Tax
Profit Before Tax stands at ₹11.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.64 per cent from ₹14.00 crore. This corresponds to a year-on-year *(YoY) growth of 54.96 per cent.
Net Profit
Net Profit stands at ₹10.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.86 per cent from ₹10.48 crore. This represents a 79.67 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Fredun Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Fredun Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Fredun Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Fredun Pharmaceuticals Ltd Financial Reports
Fredun Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Fredun Pharma | -2.99% | -2.71% | 7.86% | 36.01% | 88.74% | 192.55% |
| Windlas Biotech | 3.22% | 2.35% | 1.71% | -1.26% | 9.91% | -4.92% |
| Titan Biotech | 0.08% | 9.31% | -0.92% | -9.50% | 120.08% | 366.38% |
| Amrutanjan Healt | 1.70% | 1.95% | 0.05% | -3.50% | -10.71% | -20.83% |
| Jagsonpal Pharma | -0.54% | -1.31% | 0.20% | 13.55% | 34.86% | -10.59% |
| Shukra Pharma. | -0.12% | -4.72% | 11.41% | -0.21% | -27.89% | 56.53% |
| Fermenta Biotec. | 2.71% | -1.70% | 29.67% | 40.90% | 35.95% | 16.82% |
Company Info
Company Information
Chairman / Executive Director / Joint MD : Daulat N Medhora
Executive Director / Managing Director / CFO : Fredun N Medhora
Independent Non Exe. Director : Daisy Dsouza
Independent Non Exe. Director : Anshu Agarwal
Independent Non Exe. Director : Sonal Desai
Independent Non Exe. Director : Pooja Narendra Sanghavi
Company Sec. & Compli. Officer : Vaishnavi Rajkamal Sahu